{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T18:46:27Z","timestamp":1761763587919},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1016\/s0090-4295(01)01213-4","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T16:41:56Z","timestamp":1027615316000},"page":"146-150","source":"Crossref","is-referenced-by-count":63,"title":["Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression"],"prefix":"10.1016","volume":"58","author":[{"given":"M","family":"Wirth","sequence":"first","affiliation":[]},{"given":"C","family":"Tyrrell","sequence":"additional","affiliation":[]},{"given":"M","family":"Wallace","sequence":"additional","affiliation":[]},{"given":"K.P","family":"Delaere","sequence":"additional","affiliation":[]},{"given":"M","family":"S\u00e1nchez-Chapado","sequence":"additional","affiliation":[]},{"given":"J","family":"Ramon","sequence":"additional","affiliation":[]},{"given":"J","family":"Hetherington","sequence":"additional","affiliation":[]},{"given":"F","family":"Pina","sequence":"additional","affiliation":[]},{"given":"C.F","family":"Heynes","sequence":"additional","affiliation":[]},{"given":"T.M","family":"Borchers","sequence":"additional","affiliation":[]},{"given":"T","family":"Morris","sequence":"additional","affiliation":[]},{"given":"A","family":"Stone","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0090-4295(01)01213-4_BIB1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3322\/canjclin.48.1.6","article-title":"Cancer statistics, 1998","volume":"48","author":"Landis","year":"1998","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/S0090-4295(01)01213-4_BIB2","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0022-5347(05)67032-2","article-title":"Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer","volume":"164","author":"Iversen","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/S0090-4295(01)01213-4_BIB3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1078-1439(00)00118-6","article-title":"The bicalutamide early prostate cancer program","volume":"6","author":"See","year":"2001","journal-title":"Urol Oncol"},{"key":"10.1016\/S0090-4295(01)01213-4_BIB4","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/S0959-8049(99)80699-6","article-title":"Long term results of immediate adjuvant hormonal therapy with goserelin in patients with locally advanced prostate cancer treated with radiotherapy\u2014a phase III EORTC study","volume":"35","author":"Bolla","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1016\/S0090-4295(01)01213-4_BIB5","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJM199912093412401","article-title":"Immediate hormonal therapy in men with node-positive prostate cancer","volume":"341","author":"Messing","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/S0090-4295(01)01213-4_BIB6","first-page":"335","article-title":"Adjuvant antiandrogenic treatment after radical prostatectomy in stage C prostate cancer\u2014preliminary results of a randomized controlled multicenter trial","volume":"157","author":"Wirth","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/S0090-4295(01)01213-4_BIB7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1464-410X.1997.d01-6840.x","article-title":"Immediate versus deferred treatment for advanced prostatic cancer","volume":"79","year":"1997","journal-title":"Br J Urol"},{"key":"10.1016\/S0090-4295(01)01213-4_BIB8","unstructured":"Kirk D, on behalf of the Medical Research Council Prostate Cancer Working Party Investigators Group: Immediate vs deferred hormone treatment for prostate cancer: how safe is androgen deprivation (abstract)? BJU Int 86: 220, 2000."},{"key":"10.1016\/S0090-4295(01)01213-4_BIB9","first-page":"257","article-title":"A study of the effects of radiation on the prevention of gynaecomastia due to oestrogen therapy","volume":"5","author":"Waterfall","year":"1979","journal-title":"Clin Oncol"},{"key":"10.1016\/S0090-4295(01)01213-4_BIB10","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0360-3016(86)90359-7","article-title":"Radiotherapeutic prophylaxis of estrogen-induced gynecomastia","volume":"12","author":"Fass","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S0090-4295(01)01213-4_BIB11","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0360-3016(88)90321-5","article-title":"Effective radiotherapy in palliating mammalgia associated with gynecomastia after DES therapy","volume":"15","author":"Chou","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S0090-4295(01)01213-4_BIB12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0360-3016(99)90236-5","article-title":"Does prophylactic radiotherapy prevent antiandrogen induced gynecomastia? Evaluation of patients in the randomized Scandinavian trial SPCG7\/SFUO-3 (abstract)","volume":"45","author":"Widmark","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S0090-4295(01)01213-4_BIB13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0090-4295(97)00457-3","article-title":"Tamoxifen for flutamide\/finasteride-induced gynecomastia","volume":"50","author":"Staiman","year":"1997","journal-title":"Urology"},{"key":"10.1016\/S0090-4295(01)01213-4_BIB14","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0022-5347(01)63595-X","article-title":"Tamoxifen as treatment for gynecomastia and mastodynia resulting from hormonal deprivation","volume":"159","author":"Serels","year":"1998","journal-title":"J Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429501012134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429501012134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T18:54:50Z","timestamp":1556218490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429501012134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["S0090429501012134"],"URL":"https:\/\/doi.org\/10.1016\/s0090-4295(01)01213-4","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}